Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Soliris. Always confirm against the full prescribing information.
100 interactions
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Eculizumab.
Level 2 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Eculizumab.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Eculizumab.
Level 2 evidence
Abacavir
Abacavir may increase the hepatotoxic activities of Eculizumab.
Level 2 evidence
Abemaciclib
Eculizumab may increase the hepatotoxic activities of Abemaciclib.
Level 2 evidence
Abiraterone
Abiraterone may increase the hepatotoxic activities of Eculizumab.
Level 2 evidence
Acamprosate
Acamprosate may increase the hepatotoxic activities of Eculizumab.
Level 2 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Eculizumab.
Level 2 evidence
Acebutolol
Acebutolol may increase the hepatotoxic activities of Eculizumab.
Level 2 evidence
Aceclofenac
Eculizumab may increase the hepatotoxic activities of Aceclofenac.
Level 2 evidence
Acetaminophen
Acetaminophen may increase the hepatotoxic activities of Eculizumab.
Level 2 evidence
Acetazolamide
Acetazolamide may increase the hepatotoxic activities of Eculizumab.
Level 2 evidence
Enter your NPI to unlock 31 major interactions for Soliris
Soliris (Eculizumab) has 774 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Soliris (Eculizumab) has 219 major, 38 moderate, and 517 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Soliris. Always confirm against the full prescribing information.